| Drug-Drug Interaction Study of Atumelnant in Healthy Participants (NCT07570082) | Crinetics Pharmaceuticals Inc. | 2026-05-28 |
| A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) (NCT07159841) | Crinetics Pharmaceuticals Inc. | 2026-01-22 |
| A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia (NCT07144163) | Crinetics Pharmaceuticals Inc. | 2025-12-11 |
| A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors (NCT07129252) | Crinetics Pharmaceuticals Inc. | 2025-11-26 |
| Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen (NCT07087054) | Crinetics Pharmaceuticals Inc. | 2025-11-19 |
| A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants (NCT07221084) | Crinetics Pharmaceuticals Inc. | 2025-10-28 |
| An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia (NCT06712823) | Crinetics Pharmaceuticals Inc. | 2025-02-25 |
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome (NCT05804669) | Crinetics Pharmaceuticals Inc. | 2023-10-12 |
| Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) (NCT05907291) | Crinetics Pharmaceuticals Inc. | 2023-07-03 |
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome (NCT05361668) | Crinetics Pharmaceuticals Inc. | 2022-04-22 |
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) (NCT05192382) | Crinetics Pharmaceuticals Inc. | 2021-12-17 |
| Single and Multiple-Ascending Dose Study of CRN04894 in Healthy Volunteers (NCT06048887) | Crinetics Pharmaceuticals Inc. | 2020-12-18 |
| A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance) (NCT04261712) | Crinetics Pharmaceuticals Inc. | 2020-01-29 |
| Mass Balance and Pharmacokinetics of [14C]-CRN00808 in Healthy Volunteers (NCT04246749) | Crinetics Pharmaceuticals Inc. | 2019-09-17 |
| A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers (NCT03936166) | Crinetics Pharmaceuticals Inc. | 2019-04-29 |
| An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) (NCT03789656) | Crinetics Pharmaceuticals Inc. | 2019-03-12 |
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) (NCT03792555) | Crinetics Pharmaceuticals Inc. | 2019-03-11 |
| Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers (NCT03276858) | Crinetics Pharmaceuticals Inc. | 2017-09-22 |